This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-8.UchinoSKellumJABellomoRet alAcute renal failure in critically ill patients: a multinational, multicenter studyJAMA2005294813810.1001/jama.294.7.813Search in Google Scholar
Violo L, De Francesco M. Timing of Continuous Renal Replacement Therapy. JAMA Surg. 2018;153:289-90.VioloLDeFrancesco MTiming of Continuous Renal Replacement TherapyJAMA Surg20181532899010.1001/jamasurg.2017.5037Search in Google Scholar
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:179-84.KhwajaAKDIGO clinical practice guidelines for acute kidney injuryNephron Clin Pract20121201798410.1159/000339789Search in Google Scholar
Fealy N, Aitken L, Toit Ed, Baldwin I Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care units.Crit Care Resusc. 2015; 17:83-91.FealyNAitkenLToitEdBaldwin I Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care unitsCrit Care Resusc201517839110.1016/S1441-2772(23)01065-7Search in Google Scholar
Gould D, Doidge J, Sadique M et al. Renal replacement anticoagulant management: Protocol and analysis plan for an observational comparative effectiveness study of linked data sources. Journal of the Intensive Care Society 2020 10.1177/1751143720913417GouldDDoidgeJSadiqueMet alRenal replacement anticoagulant management: Protocol and analysis plan for an observational comparative effectiveness study of linked data sourcesJournal of the Intensive Care Society202010.1177/1751143720913417Open DOISearch in Google Scholar
Brandenburger T, et al. Renal replacement therapy and anticoagulation. Best Practice $ Research Clinical Anesthesiology 2017;387-401BrandenburgerTet alRenal replacement therapy and anticoagulationBest Practice $ Research Clinical Anesthesiology2017387–40110.1016/j.bpa.2017.08.005Search in Google Scholar
Clark W, Villa G, Ronco C. Continuous Renal Replacement Therapy Machine Technology, Critical Care Nephrology, 2019,141;853-860ClarkWVillaGRoncoCContinuous Renal Replacement Therapy Machine TechnologyCritical Care Nephrology2019141853–86010.1016/B978-0-323-44942-7.00141-2Search in Google Scholar
Meersch M, Küllmar M, Wempe C, et al. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial. BMJ Open. 2019;9(1)MeerschMKüllmarMWempeCet alRegional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trialBMJ Open20199110.1136/bmjopen-2018-024411Search in Google Scholar
Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Crit Care. 2011;15:202.Oudemans-vanStraaten HMKellumJABellomoRClinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?Crit Care20111520210.1186/cc9358Search in Google Scholar
Miklaszewska M, Korohoda P, Zachwieja K, et al. Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival. Kidney Blood Press Res. 2017;42:327-37.MiklaszewskaMKorohodaPZachwiejaKet alFilter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit SurvivalKidney Blood Press Res2017423273710.1159/000477609Search in Google Scholar
Martindale SJ, Shayevitz JR, D’Errico C. The activated coagulation time: suitability for monitoring heparin effect and neutralisation during pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10:458-63.MartindaleSJShayevitzJRD’ErricoCThe activated coagulation time: suitability for monitoring heparin effect and neutralisation during pediatric cardiac surgeryJ Cardiothorac Vasc Anesth1996104586310.1016/S1053-0770(05)80004-7Search in Google Scholar
Aarab R, van Es J, de Pont AC, Vroom MB, Middeldorp S. Monitoring of unfractionated heparin in critically ill patients. Neth J Med. 2013;71:466-71.AarabRvanEs JdePont ACVroomMBMiddeldorpSMonitoring of unfractionated heparin in critically ill patientsNeth J Med20137146671Search in Google Scholar
Li F., Gross A. Considerations for Medication Management and Anticoagulation During Continuous Renal Replacement Therapy. AACN Advanced Critical Care, 2017,28(1), 51–63LiF.GrossAConsiderations for Medication Management and Anticoagulation During Continuous Renal Replacement TherapyAACN Advanced Critical Care2017281516310.4037/aacnacc201738628254856Search in Google Scholar
Ostermann M, Dickie H, Tovey L, Treacher D. Heparin algorithm for anticoagulation during continuous renal replacement therapy. Crit Care. 2010; 14:419OstermannMDickieHToveyLTreacherDHeparin algorithm for anticoagulation during continuous renal replacement therapyCrit Care20101441910.1186/cc9003291170620519031Search in Google Scholar
Gabrielli A, Layon AJ, Yu M, Civetta JM, Taylor RW, Kirby RR. Civetta Taylor and Kirbys Critical Care, Fourth Edition. Philadelphia: Lippincott Williams & Wilkins, 2009. Print.GabrielliALayonAJYuMCivettaJMTaylorRWKirbyRRCivetta Taylor and Kirbys Critical Care, Fourth EditionPhiladelphiaLippincott Williams & Wilkins2009PrintSearch in Google Scholar
Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(1 Suppl):64S–94SHirshJWarkentinTEShaughnessySGet alHeparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyChest20011191 Suppl64S94S10.1378/chest.119.1_suppl.64S11157643Search in Google Scholar
de Swart CA, Nijmeyer B, Roelofs JM, Sixma JJ. Kinetics of intravenously administered heparin in normal humans. Blood. 1982;60:1251-8deSwart CANijmeyerBRoelofsJMSixmaJJKinetics of intravenously administered heparin in normal humansBlood1982601251810.1182/blood.V60.6.1251.1251Search in Google Scholar
Coene KLM, van der Graaf F, van de Kerkhof D. Protocolled Redefinition of the Therapeutic Range for Unfractionated Heparin: Lost in Translation?. Clin Appl Thromb Hemost. 2018;24:164-71CoeneKLMvander Graaf Fvande Kerkhof DProtocolled Redefinition of the Therapeutic Range for Unfractionated Heparin: Lost in Translation?Clin Appl Thromb Hemost2018241647110.1177/1076029616679508671463927856667Search in Google Scholar
Shapiro GA, Huntzinger SW, Wilson JE 3rd. Variation among commercial activated partial thromboplastin time reagents in response to heparin. Am J Clin Pathol. 1977;67:477-80.ShapiroGAHuntzingerSWWilsonJE 3rdVariation among commercial activated partial thromboplastin time reagents in response to heparinAm J Clin Pathol1977674778010.1093/ajcp/67.5.477857645Search in Google Scholar
Eikelboom JW, Hirsh J. Monitoring unfractionated heparin with the aPTT: time for a fresh look. Thromb Haemost. 2006;96:547-52.EikelboomJWHirshJMonitoring unfractionated heparin with the aPTT: time for a fresh lookThromb Haemost2006965475210.1160/TH06-05-0290Search in Google Scholar
Niederdöckl J, Dempfle CE, Schönherr HR, et al. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors. Int J Lab Hematol. 2016;38:42-34.NiederdöcklJDempfleCESchönherrHRet alPoint-of-care PT and aPTT in patients with suspected deficiencies of coagulation factorsInt J Lab Hematol201638423410.1111/ijlh.1251927384253Search in Google Scholar
Stein P, Kaserer A, Spahn GH, Spahn DR. Point-of-Care Coagulation Monitoring in Trauma Patients. Semin Thromb Hemost. 2017;43:367-74.SteinPKasererASpahnGHSpahnDRPoint-of-Care Coagulation Monitoring in Trauma PatientsSemin Thromb Hemost2017433677410.1055/s-0037-159806228297730Search in Google Scholar
Zimmerman CR. The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders. J Thromb Thrombolysis. 2000;9:187-98.ZimmermanCRThe role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disordersJ Thromb Thrombolysis200091879810.1023/A:1018744124955Search in Google Scholar
Baldwin I, Bridge N, Heland M, et al. The effect of heparin administration site on extracorporeal circuit life during continuous venovenous hemofiltration. Aust Crit Care 1996;1:29.BaldwinIBridgeNHelandMet alThe effect of heparin administration site on extracorporeal circuit life during continuous venovenous hemofiltrationAust Crit Care199612910.1016/S1036-7314(96)70325-9Search in Google Scholar
Leslie GD, Jacobs IG, Clarke GM. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration. Intensive Care Med. 1996;22:1261-4.LeslieGDJacobsIGClarkeGMProximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltrationIntensive Care Med1996221261410.1007/BF017093469120123Search in Google Scholar
Brain M, Winson E, Roodenburg O, McNeil J. Non anticoagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis. BMC Nephrol. 2017;18:69.BrainMWinsonERoodenburgOMcNeilJNon anticoagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysisBMC Nephrol2017186910.1186/s12882-017-0445-5531903128219324Search in Google Scholar
Laxson CJ, Titler MG. Drawing coagulation studies from arterial lines: an integrative literature review. Am J Crit Care. 1994;3:16-24.LaxsonCJTitlerMGDrawing coagulation studies from arterial lines: an integrative literature reviewAm J Crit Care19943162410.4037/ajcc1994.3.1.16Search in Google Scholar
Kordzadeh A, Austin T, Panayiotopoulos Y. Efficacy of normal saline in the maintenance of the arterial lines in comparison to heparin flush: a comprehensive review of the literature. J Vasc Access. 2014;15:123-7.KordzadehAAustinTPanayiotopoulosYEfficacy of normal saline in the maintenance of the arterial lines in comparison to heparin flush: a comprehensive review of the literatureJ Vasc Access201415123710.5301/jva.500018324101417Search in Google Scholar
Moossavi S, Vachharajani TJ, Jordan J, Russell GB, Kaufman T, Moossavi S. Retrospective analysis of catheter recirculation in prevalent dialysis patients. Semin Dial. 2008;21:289-92.MoossaviSVachharajaniTJJordanJRussellGBKaufmanTMoossaviSRetrospective analysis of catheter recirculation in prevalent dialysis patientsSemin Dial2008212899210.1111/j.1525-139X.2008.00442.x18533970Search in Google Scholar
